First Trust Advisors LP Cabaletta Bio, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $251,664 - $449,400	-35,952 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$7.2 - $11.73 $1,749 - $2,850	-243 Reduced 0.67%	35,952 $309,000
Q1 2021 May 14, 2021	BUY	$10.39 - $14.53 $30,182 - $42,209	2,905 Added 8.73%	36,195 $402,000
Q4 2020 Feb 02, 2021	SELL	$9.81 - $15.8 $14,459 - $23,289	-1,474 Reduced 4.24%	33,290 $415,000
Q3 2020 Nov 05, 2020	BUY	$9.71 - $14.41 $337,558 - $500,949	34,764 New	34,764 $377,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.